These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14552429)

  • 21. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.
    Asimakopoulos FA; Holloway TL; Nacheva EP; Scott MA; Fenaux P; Green AR
    Blood; 1996 Feb; 87(4):1561-70. PubMed ID: 8608248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders.
    Hutchinson RM
    Leuk Lymphoma; 1992 May; 7(1-2):29-36. PubMed ID: 1472931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes.
    Dickstein JI; Vardiman JW
    Am J Clin Pathol; 1993 Apr; 99(4):513-25. PubMed ID: 8475918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A revised 4 edition WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2017: myeloid neoplasms].
    Kovrigina AM
    Arkh Patol; 2018; 80(6):43-49. PubMed ID: 30585592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes.
    Adeyinka A; Dewald GW
    Hematol Oncol Clin North Am; 2003 Oct; 17(5):1129-49. PubMed ID: 14560778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients.
    Garza J; Anderson JM; Scherber RM
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):475-489. PubMed ID: 32089224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelodysplasia and myeloproliferative disorders in children.
    McKenna RW
    Am J Clin Pathol; 2004 Dec; 122 Suppl():S58-69. PubMed ID: 15690643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders.
    Lamour C; Bergeron A
    Rev Mal Respir; 2011 Jun; 28(6):e18-27. PubMed ID: 21742229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
    Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
    Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
    Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
    Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
    Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
    Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
    Wang SA; Hasserjian RP; Tam W; Tsai AG; Geyer JT; George TI; Foucar K; Rogers HJ; Hsi ED; Rea BA; Bagg A; Bueso-Ramos CE; Arber DA; Verstovsek S; Orazi A
    Haematologica; 2017 Aug; 102(8):1352-1360. PubMed ID: 28495918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center.
    González-Medina I; Bueno J; Torrequebrada A; López A; Vallespí T; Massagué I
    Leuk Res; 2002 Sep; 26(9):821-4. PubMed ID: 12127557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy.
    Delacrétaz F; Schmidt PM; Piguet D; Bachmann F; Costa J
    Am J Clin Pathol; 1987 Feb; 87(2):180-6. PubMed ID: 3812349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelopoiesis and myeloproliferative disorders.
    Raskin RE
    Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1023-42. PubMed ID: 8863389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
    Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618
    [No Abstract]   [Full Text] [Related]  

  • 40. Sideroblastic anaemia with reactive thrombocytosis versus myelodysplastic/myeloproliferative disease.
    Pérez Sánchez I; Pérez Corrala A; Menarguez Palanca J; Mayayo Crespo M; Escudero Soto A; Pintado Cros T
    Leuk Lymphoma; 2003 Mar; 44(3):557-9. PubMed ID: 12688334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.